Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Neurology|June 25, 2011
Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer diseaseM D Ikonomovic, W E Klunk, E E Abrahamson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 1998
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imagingC C Meltzer, G Smith, S T DeKosky, et al.
Biological Psychiatry|February 13, 2001
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoriaW C Drevets, C Gautier, J C Price, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 1, 1991
Diminished glucose transport in Alzheimer's disease: dynamic PET studiesW J Jagust, J P Seab, R H Huesman, et al.
Journal of Computer Assisted Tomography|August 1, 1983
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucoseR P Friedland, T F Budinger, E Ganz, et al.
Synapse (New York, N.Y.)|December 1, 1995
Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent modelC P Lawler, J H Gilmore, V J Watts, et al.
Neurology|November 1, 1989
Regional cerebral glucose transport and utilization in Alzheimer's diseaseR P Friedland, W J Jagust, R H Huesman, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1992
Binding potency of paroxetine analogues for the 5-hydroxytryptamine uptake complexC A Mathis, J M Gerdes, J D Enas, et al.
Synapse (New York, N.Y.)|May 17, 2001
Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humansJ C Price, B J Lopresti, C C Meltzer, et al.
Pageof 6